LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after – – Continued favorable safety profile observed in masked ...

There has been an increase in fabricated references used in medical papers, according to a research letter published in the May 9 issue of The Lancet. Maxim Top ...

LMC representatives from around the UK have demanded that Governments ensure any advice and guidance (A&G) systems 'are ...

May 14, 2026Biodexa issues letter to ShareholdersBiodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage ...

We read with interest the letter by Kwok Chiu Chang and appreciate the potential implications they raise for individuals in settings in which rapid, reliable, and complete drug susceptibility testing ...

An investigation concluded that Yale School of Medicine favored Black and Hispanic applicants. The Justice Department sent ...

Broyhill Equity Composite declined 6.0% in Q1 2026, lagging global benchmarks. Read the full analysis for insights on ...

FDA’s final SIUU guidance loosens some off-label communication rules, but drugmakers still face strict compliance demands to ...

The number of fabricated citations in published research studies is a rapidly growing problem, finds a new study, and AI ...

Makary’s time as FDA head brought a series of moves designed to speed up the regulatory process and bring greater transparency to the pathway to approval. In February, Makary and top deputy Vinay ...

Broyhill Asset Management details its Q1 2026 performance and portfolio shifts, highlighting major contributors and new ...

Once more the Dayton Daily News has given Frank LaRose a forum to spew his grievances. This time it’s politically motivated ...